Literature DB >> 30656618

Making NSC and Neurons from Patient-Derived Tissue Samples.

Odity Mukherjee1, Shubhra Acharya2, Mahendra Rao2,3.   

Abstract

The human brain and mechanisms underlying its functioning has been a field of intense research due to its complexity, inaccessibility, and the large numbers of debilitating disorders affecting this organ. Model organisms have provided great insight into the functioning of the mammalian brain; however, there exist many features unique to humans which need detailed understanding. In this context, human pluripotent stem cells (HPSCs) have emerged as a promising resource.In the developing brain, cortical diversification is achieved by neural stem cells/neural progenitor cells (NSCs/NPCs) by altering its potency (from multipotent to unipotent) and differentiation capacity (from neurogenesis to gliogenesis). Recent development in tissue reprogramming allows for derivation of NSCs/NPCs from either healthy control subjects manipulated to carry disease mutations or affected individuals carrying specific disease-causing mutations allowing for detailed evaluation of cellular phenotype, pharmacological manipulation, and/or toxicological screening.In this chapter, we will discuss HPSC differentiation into neural stem cells (NSCs) and neurons. We will review the mechanism underlying in vivo neural differentiation and methods which recapitulate this in vitro. We describe a method of deriving NSCs and differentiated mature neurons highlighting key steps of the core protocol. We also provide detailed information of the transcription factor and morphogen map of the developing brain which can be used as a guide to derive region- and lineage-specific NSCs and differentiated neurons.

Entities:  

Keywords:  Directed differentiation; Human pluripotent stem cells; In vitro neuronal differentiation; In vitro neuronal regionalization; Induced differentiation

Mesh:

Substances:

Year:  2019        PMID: 30656618     DOI: 10.1007/978-1-4939-9007-8_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  APP and DYRK1A regulate axonal and synaptic vesicle protein networks and mediate Alzheimer's pathology in trisomy 21 neurons.

Authors:  Chun-I Wu; Elizabeth A Vinton; Richard V Pearse; Keunjung Heo; Aimee J Aylward; Yi-Chen Hsieh; Yan Bi; Sopefoluwa Adeleye; Seeley Fancher; Duc M Duong; Nicholas T Seyfried; Thomas L Schwarz; Tracy L Young-Pearse
Journal:  Mol Psychiatry       Date:  2022-02-23       Impact factor: 13.437

Review 2.  Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events.

Authors:  Elena Genova; Federica Cavion; Marianna Lucafò; Luigina De Leo; Marco Pelin; Gabriele Stocco; Giuliana Decorti
Journal:  World J Stem Cells       Date:  2019-12-26       Impact factor: 5.326

3.  A human stem cell resource to decipher the biochemical and cellular basis of neurodevelopmental defects in Lowe syndrome.

Authors:  Bilal M Akhtar; Priyanka Bhatia; Shubhra Acharya; Sanjeev Sharma; Yojet Sharma; Aswathy Bhuvanendran Nair Suseela Devi; Kavina Ganapathy; Anil Vasudevan; Padinjat Raghu
Journal:  Biol Open       Date:  2022-02-04       Impact factor: 2.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.